Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
about
Salvianolic acid B inhibits hydrogen peroxide-induced endothelial cell apoptosis through regulating PI3K/Akt signalingThe MiRNA Journey from Theory to Practice as a CNS BiomarkerBlood-Based Proteomic Biomarkers of Alzheimer's Disease PathologyThe pericyte: a forgotten cell type with important implications for Alzheimer's disease?Cerebrovascular effects of apolipoprotein E: implications for Alzheimer diseaseCerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's diseaseIdentification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implicationsSilencing microRNA-143 protects the integrity of the blood-brain barrier: implications for methamphetamine abuseA novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drugPhosphatase 2A Inhibition Affects Endoplasmic Reticulum and Mitochondria Homeostasis Via Cytoskeletal Alterations in Brain Endothelial CellsNeurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersPathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesisFibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's diseaseCCL2 disrupts the adherens junction: implications for neuroinflammationCerebral vascular leak in a mouse model of amyloid neuropathology.Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdownApolipoprotein E controls cerebrovascular integrity via cyclophilin A.Effects of insulin and octreotide on memory and growth hormone in Alzheimer's diseaseThe future of blood-based biomarkers for Alzheimer's disease.The vascular contribution to Alzheimer's disease.The blood-brain barrier in health and disease.Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people.The impact of microglial activation on blood-brain barrier in brain diseases.Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice.The overlap between vascular disease and Alzheimer's disease--lessons from pathology.Framingham Coronary Heart Disease Risk Score Can be Predicted from Structural Brain Images in Elderly Subjects.APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role?Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer's disease mice.Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases.Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease.Safety and pharmacological characterization of the molecular tweezer CLR01 - a broad-spectrum inhibitor of amyloid proteins' toxicity.Blood-brain barrier breakdown in the aging human hippocampusInteractive effects of apolipoprotein E4 and diabetes risk on later myelinating white matter regions in neurologically healthy older aged adultsUpregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma.Comparison of Vascular Perturbations in an Aβ-Injected Animal Model and in AD Brain.Soluble aggregates of the amyloid-beta protein selectively stimulate permeability in human brain microvascular endothelial monolayers.Pericytes contribute to the disruption of the cerebral endothelial barrier via increasing VEGF expression: implications for stroke.Simvastatin blocks blood-brain barrier disruptions induced by elevated cholesterol both in vivo and in vitro.A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain.Blood-Brain Barrier Disruption Is an Early Event That May Persist for Many Years After Traumatic Brain Injury in Humans.
P2860
Q21144404-5F10CF1C-016E-4B65-9F3F-CFE14A701525Q26767457-88414D36-E199-4861-BE61-0A8CE1AB8268Q26774743-5FF38118-544F-4B64-A9F1-3D52DCDCE27FQ26852369-9EB2FDA5-FBF3-496B-8A4D-50386DD1D5BCQ27008456-774ECA1F-04CA-4242-8003-6D06DAEA3A8EQ28087176-6D553A6B-72A4-424F-B0DA-739FD42D0B2AQ28282373-EF119666-F749-452C-9064-9BD9824BF4B1Q28392130-DCF46D7F-9C43-443D-8493-CBF6A99B8749Q28540639-05F2AD50-2BCF-4E3B-B026-A83B34C27328Q28771363-5D98AA2F-2EDA-452E-9D1E-FC6D6FBE27E1Q29615839-2C73F87C-1239-4F01-A2EF-77A2C78F5624Q30235369-D01959B5-3566-489C-9705-7990BD27764FQ30495250-9DB8E844-7A19-4C2A-90C2-9490CEFCFC50Q30523821-A6C9AC3E-4710-4E9B-BA8E-924F1A5306A5Q30609094-F15D7811-8A3B-4966-898E-3761BE44599CQ33717021-21A9DC6C-F47E-4DEF-B7A0-48ABB4CD8AB6Q33717326-E222C607-BA05-40E2-897E-5A2914D1B578Q33742199-3C363152-7350-41E3-988B-8760FBC93E03Q34026317-6E9D199A-3B6E-4F7E-8F57-780DC97184D2Q34178526-DDCC0ED2-BAF6-482C-B3D9-BC1E8059B4D3Q34320420-6BB184E5-89D9-4455-9C59-001C6B291017Q34406773-628F18D1-840D-4362-A2B1-50B4927A1300Q34442604-7B547C1E-4964-46EC-948D-1BB86403944DQ34465222-AF4EAA65-2EAC-4EFF-8B54-6058FF27C900Q34484708-C8B14864-43E0-4885-9AF2-BE191D36CB30Q34597077-ECB8DD8C-FCE3-4A67-879D-E156F1BFC110Q34613047-39ADC0F6-7BA8-4BB3-83E8-2186F551F988Q34704978-A68A74E5-D30C-4119-8D25-AC1205F85F91Q34905120-A51A55CA-D3D8-4E44-8468-454C4931BE60Q35034769-BE4BD991-7283-40E3-ABF3-64F617EF8863Q35148785-67234653-5582-49C8-A337-43C152E5A697Q35151019-BF2EAE27-4B9C-4BB7-A90D-2B79D59A77F6Q35167347-1EEBF28F-CBDF-4761-AFC5-A3FB6D9BA063Q35191570-6089D817-66AA-41FE-A0A6-E87D1871CA8DQ35240139-1B6DF319-D0A9-459E-B40D-A0DE2B664362Q35525050-60D99E97-B45E-48B9-973A-96D53FCA24F3Q35605557-66882D4C-01F5-43A9-A198-77B1A4330523Q35810686-41A9819B-07D6-47D2-B9E9-BF9AE2C49DD5Q35841946-D88207B4-D67F-40A1-9C1C-B976C36B6C54Q35843379-70DB4F1C-DF49-4740-86F6-77F182BCBBB4
P2860
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
@ast
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
@en
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
@nl
type
label
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
@ast
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
@en
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
@nl
prefLabel
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
@ast
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
@en
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
@nl
P2093
P1476
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
@en
P2093
Gonzalez L
Hovanesian V
Hulette CM
Johanson CE
P304
P356
10.1016/J.NEUROBIOLAGING.2006.05.016
P577
2006-06-16T00:00:00Z